Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

OPC Pharmaceutical JSC (OPC)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
25,400.0 -100.0    -0.39%
07:32:52 - Real-time Data. Currency in VND ( Disclaimer )
  • Volume: 2,600
  • Bid/Ask: 25,400.0 / 25,450.0
  • Day's Range: 25,350.0 - 25,500.0
Type:  Equity
Market:  Vietnam
ISIN:  VN000000OPC9 
OPC Pharmaceutical JSC 25,400.0 -100.0 -0.39%

OPC Balance Sheet

 
Assess the latest OPC Pharmaceutical JSC balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced OPC Annual Report data, financial summaries and charts are available for OPC Pharmaceutical JSC investors with their own InvestingPro account.
AnnualQuarterly
Advanced Balance Sheet
Collapse All
Period Ending: 2024
31/03
 2023
31/12
 2023
30/09
 2023
30/06
Total Current Assets 877253.11 931391.7 859364.97 836721.14
Cash and Short Term Investments 302296.7 321361 225813.7 228720.44
Cash - - - -
Cash & Equivalents 270727.74 294273.72 189551.53 180635.74
Short Term Investments 31500 27018.32 36193.22 48015.75
Total Receivables, Net 180126.67 220304.26 221162.91 216427.4
Accounts Receivables - Trade, Net 174543.58 219051.76 220806.87 215236.03
Total Inventory 369498.77 362396.6 388649.25 371647.58
Prepaid Expenses 1111.92 1028.92 3362.37 4037.34
Other Current Assets, Total 24219.06 26300.92 20376.74 15888.38
Total Assets 1200787.07 1264586.64 1183651.72 1167162.14
Property/Plant/Equipment, Total - Net 167332.87 171072.9 169010.82 174676.49
Property/Plant/Equipment, Total - Gross 581032.66 579434.57 571996.51 572175.96
Accumulated Depreciation, Total -413699.8 -408361.67 -402985.69 -397499.47
Goodwill, Net - - - -
Intangibles, Net 73654.36 73927.85 74205.1 74482.35
Long Term Investments 24684.98 24429.64 24483 24395.1
Note Receivable - Long Term 5583.09 1252.5 356.04 1191.36
Other Long Term Assets, Total 54154.64 54241.15 54682.71 55124.27
Other Assets, Total 248867.23 205003.94 226030.38 220956.05
Total Current Liabilities 293249.27 375449.13 318389.01 333467.88
Accounts Payable 33113.9 43575.47 28329.28 32485.56
Payable/Accrued - - - -
Accrued Expenses 40240.72 89961.73 66634.81 76580.74
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 219894.65 241911.93 223424.91 224401.57
Total Liabilities 298054.31 380359.84 323603.73 338757.61
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest 63630.85 62216.19 62533.86 62705.18
Other Liabilities, Total -58825.81 -57305.48 -57319.14 -57415.45
Total Equity 902732.77 884226.79 860047.99 828404.53
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 640508.92 640508.92 640508.92 640508.92
Additional Paid-In Capital 880.7 880.7 880.7 880.7
Retained Earnings (Accumulated Deficit) 197712.29 180620.99 156124.51 124309.73
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 63630.85 62216.19 62533.86 62705.18
Total Liabilities & Shareholders' Equity 1200787.07 1264586.64 1183651.72 1167162.14
Total Common Shares Outstanding 75.36 64.05 64.05 64.05
Total Preferred Shares Outstanding - - - -
* In Millions of VND (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

OPC Price Commentary

Write your thoughts about OPC Pharmaceutical JSC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email